Snowball logo
logo
MRK_logo

MERCK Kommanditgesellschaft auf Aktien

139.50-0.50  (0.36%)
Estimate
P/E
24
EPS
5.82
Beta
0.809
Growth
Revenue, YoY
-2.77%
Net income, YoY
-10.2%
FCF, YoY
1,040.63%
Forecast
P/E (FWD)
15.9
EPS (FWD)
8.768
Dividends
Dividend yield
1.58%
Annual payout
2.20
Next ex. div date
April 27, 27
Payout
11.76%
Div.growth, 5y
-3.29%
Div.rating
About the company
Ticker
MRK
ISIN
DE0006599905
Country
Germany
Sector (GICS)
Healthcare
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a sub

Frequently asked questions

What sector does MERCK Kommanditgesellschaft auf Aktien (MRK) operate in?

MERCK Kommanditgesellschaft auf Aktien belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is MERCK Kommanditgesellschaft auf Aktien (MRK) current stock price?

As of the latest data, MERCK Kommanditgesellschaft auf Aktien stock price is €139.50, with a previous close of €140.00. MERCK Kommanditgesellschaft auf Aktien lost -€0.50 in the last trading session, representing a -0.36% loss.

What is MERCK Kommanditgesellschaft auf Aktien (MRK) current market capitalization?

MERCK Kommanditgesellschaft auf Aktien market cap is approximately 18.03 billion.

What is MERCK Kommanditgesellschaft auf Aktien (MRK) Earnings Per Share (EPS)?

The trailing EPS is €5.82, and the forward EPS is €8.77.

What is MERCK Kommanditgesellschaft auf Aktien (MRK) Price-to-Earnings (P/E) ratio?

MERCK Kommanditgesellschaft auf Aktien current P/E ratio is 23.97, with a forward P/E of 15.91.

What is MERCK Kommanditgesellschaft auf Aktien (MRK) EBITDA?

MERCK Kommanditgesellschaft auf Aktien EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 1.47 billion.

Does MERCK Kommanditgesellschaft auf Aktien (MRK) pay dividends?

Yes. MERCK Kommanditgesellschaft auf Aktien pays annual dividends with an annualized yield of 1.58% and an estimated annual payout of €2.20 per share.

When is the next ex-dividend date for MERCK Kommanditgesellschaft auf Aktien (MRK)?

The next ex-dividend date is scheduled for April 27, 2027.

How did MERCK Kommanditgesellschaft auf Aktien (MRK) perform in its most recent earnings report?

In the last report (March 31, 2026), MERCK Kommanditgesellschaft auf Aktien posted an EPS surprise of -21.2% and a revenue surprise of 0.97%.

When is MERCK Kommanditgesellschaft auf Aktien (MRK) next earnings report?

MERCK Kommanditgesellschaft auf Aktien is expected to release its next earnings report on June 30, 2026.

What is MERCK Kommanditgesellschaft auf Aktien (MRK) beta (volatility) score?

MERCK Kommanditgesellschaft auf Aktien has a beta of 0.809, meaning its volatility is roughly in line with the market.